Medline reprocessed St. Jude Supreme diagnostic electrophysiology catheters recalled for residual particles
Stop using affected St. Jude Supreme catheters
Certain lots of reprocessed St. Jude Supreme and Response diagnostic electrophysiology catheters distributed by Medline may contain small particles of leftover material from reprocessing. If used in patients, these particles could cause blood clots, infection, or inflammatory reactions that may lead to serious complications including stroke or blood clots in the lungs or legs.
- Check your facility's inventory against the affected lot numbers (EP250307 and EP250317)
- Stop using any affected catheters immediately
- Contact Medline or your hospital's medical device coordinator for instructions on device removal and patient notification
- Report any patient injuries or complications to the FDA MedWatch program
These lots of reprocessed catheters may contain small particles of residual material. If affected devices are used, there is a risk of inflammatory response, systemic infection, or granulomatous reaction or thrombus reaction which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. Expansion of recall Z-2610/2614-2025
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1322-2026More Medline Industries, LP recalls
- FDA-PR2026-08-05Medline Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits recalled for connector overheating risk
- FDA-Device2026-07-29Medline convenience kits with Bard Silastic Foley Catheters recalled for surface contamination
- FDA-Device2026-07-29Medline medical procedure kits recalled for pain medication quality issues
- FDA-Device2026-07-29Medline urology robotic procedure packs recalled for defective Bard Silastic Foley Catheters
- FDA-Device2026-07-29Medline medical convenience kits recalled for potential Bacillus contamination
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief